Some reports have focused on the serum level of ACE2 in HF patients, which revealed that serum ACE2 is increased in HF and indicated that ACE2 has the potential to become a reliable marker with the same efficacy as BNP.83, 84, 85. This evidence concerns the gene NPPB and hydrops fetalis.